IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
By M. Gyrd-Hansen, P. Meier. Nature Reviews. Cancer, 2010
826 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/e10c01a932d1caa51279046504778b338a336b3b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Jun He
- Rongsheng Tong
- Qiaodan Zhou
- Cheng Peng
- Haiying Lu
- Zhongliang Jiang
- Jianyou Shi
Citations in the corpus
- Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials (2020, background): “They bind to the caspase or other pro-apoptotic proteins, results in the inhibition of the proapoptotic proteins functions and promotes their degradation, thereby regulates the apoptosis.(91,92) The IAPs has eight family members: XIAP, c-IAP1, c-IAP2, ML-IAP/Livin, ILP2, NAIP, Bruce/ Apollon, and su”